Breast Carcinoma Amplified Sequence 2 (BCAS2) (C-Term) Peptid
BCAS2
Reaktivität: Human
BP
Sodium azide
-
- Target Alle BCAS2 Produkte
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Protein Region
- C-Term
- Spezies
- Human
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
-
14 amino acids near the carboxy terminus of human BCAS2.
Human
-
-
- Applikationshinweise
- BCAS2 pepide is used for blocking the activity of BCAS2.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- BCAS2 (Breast Carcinoma Amplified Sequence 2 (BCAS2))
- Synonyme
- DAM1 Peptide, SPF27 Peptide, Snt309 Peptide, 6430539P16Rik Peptide, AI132645 Peptide, C76366 Peptide, C80030 Peptide, BCAS2 Peptide, cb302 Peptide, zgc:101730 Peptide, BCAS2, pre-mRNA processing factor Peptide, breast carcinoma amplified sequence 2 Peptide, breast carcinoma amplified sequence 2 L homeolog Peptide, BCAS2 Peptide, Bcas2 Peptide, bcas2 Peptide, bcas2.L Peptide, CpipJ_CPIJ003889 Peptide
-
Sie sind hier:
